The news. The narrative. The timeline.
Bureau: Tokyo
Twenty-three calves and twenty returning mothers closed the right whale season — and the calving interval compressed back toward the historic norm for the first time in years.
The 13-former-leader letter to House and Senate Appropriators is still the loudest institutional answer to the firing of an entire 76-year-old governing body.
Idaho's H5N1 dairy vector watch holds inside the 18-state cumulative count and 70 confirmed human cases since 2024 — and the system is one host shift from a new genotype clock.
The AHA-NHLBI fund named for Eugene Braunwald has raised more than a million dollars in its first three weeks, funding the named-mentorship infrastructure his textbook helped invent.
The B-meson rare-decay deviation that worried theorists for a decade has not faded with three times the data; the next analysis cycle decides whether it converges to discovery.
NICE's June 10 reconsultation is the operative artifact in the Cochrane-versus-Kisunla fight; the carer-economics dispute, not the trial-design one, is now the regulator's center of gravity.
A click-chemistry reaction crosslinks red blood cells into a clot in five seconds, thirteen times more fracture-resistant than natural — and now moving toward the human trauma pipeline.
The Penn-NYU monocyte epigenetic-age assay for late-life cognitive depression is moving from a 440-person observation cohort into prospective validation — inflammation-aging gets a measurable proxy.
An Australian permit system can be used to require synthetic-DNA screening without new legislation; the U.S. has been silent for fourteen days while NSB has been disbanded for sixteen.